Cargando…

Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial

BACKGROUND: The STREAM stage 1 trial showed that a 9-month regimen for the treatment of rifampicin-resistant tuberculosis was non-inferior to the 20-month 2011 WHO-recommended regimen. In STREAM stage 2, we aimed to compare two bedaquiline-containing regimens with the 9-month STREAM stage 1 regimen....

Descripción completa

Detalles Bibliográficos
Autores principales:	Goodall, Ruth L, Meredith, Sarah K, Nunn, Andrew J, Bayissa, Adamu, Bhatnagar, Anuj K, Bronson, Gay, Chiang, Chen-Yuan, Conradie, Francesca, Gurumurthy, Meera, Kirenga, Bruce, Kiria, Nana, Meressa, Daniel, Moodliar, Ronelle, Narendran, Gopalan, Ngubane, Nosipho, Rassool, Mohammed, Sanders, Karen, Solanki, Rajesh, Squire, S Bertel, Torrea, Gabriela, Tsogt, Bazarragchaa, Tudor, Elena, Van Deun, Armand, Rusen, ID
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614824/ https://www.ncbi.nlm.nih.gov/pubmed/36368336 http://dx.doi.org/10.1016/S0140-6736(22)02078-5

Ejemplares similares

Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial
por: Nunn, Andrew J, et al.
Publicado: (2014)

Keeping up with the guidelines: design changes to the STREAM stage 2 randomised controlled non-inferiority trial for rifampicin-resistant tuberculosis
por: Goodall, Ruth L., et al.
Publicado: (2022)

Cost-effectiveness of new MDR-TB regimens: study protocol for the TB-PRACTECAL economic evaluation substudy
por: Sweeney, Sedona, et al.
Publicado: (2020)

Investigation of the efficacy of the short regimen for rifampicin-resistant TB from the STREAM trial
por: Phillips, P. P. J., et al.
Publicado: (2020)

Thermoregulatory effects of swaddling in Mongolia: a randomised controlled study
por: Tsogt, Bazarragchaa, et al.
Publicado: (2016)

Drug-resistant tuberculosis: Promising progress with a note of caution
por: Esmail, Hanif, et al.
Publicado: (2022)

Implementation challenges and lessons learned from the STREAM clinical trial—a survey of trial sites
por: Patel, Leena N., et al.
Publicado: (2023)

Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trial
por: Madan, Jason J, et al.
Publicado: (2020)

Challenges in Tuberculosis Clinical Trials in the Face of the COVID-19 Pandemic: A Sponsor’s Perspective
por: Rusen, I.D.
Publicado: (2020)

Cost of digital technologies and family-observed DOT for a shorter MDR-TB regimen: a modelling study in Ethiopia, India and Uganda
por: Rosu, Laura, et al.
Publicado: (2023)

QT prolongation in the STREAM Stage 1 Trial
por: Hughes, G., et al.
Publicado: (2022)

A systematic assessment of the concept and practice of public-private mix for tuberculosis care and control
por: Malmborg, Rasmus, et al.
Publicado: (2011)

Proportion and trend of primary resistance among Multidrug resistant Tuberculosis patients in Ethiopia
por: Bayissa, Adamu, et al.
Publicado: (2022)

A Systematic Review of the Prevalence and Pattern of Imaging Defined Post-TB Lung Disease
por: Meghji, Jamilah, et al.
Publicado: (2016)

What can dissaving tell us about catastrophic costs? Linear and logistic regression analysis of the relationship between patient costs and financial coping strategies adopted by tuberculosis patients in Bangladesh, Tanzania and Bangalore, India
por: Madan, Jason, et al.
Publicado: (2015)

Implementation of digital technology solutions for a lung health trial in rural Malawi
por: Chisunkha, Blessings, et al.
Publicado: (2016)

Economic evaluation protocol of a short, all-oral bedaquiline-containing regimen for the treatment of rifampicin-resistant tuberculosis from the STREAM trial
por: Rosu, Laura, et al.
Publicado: (2020)

Issues in design and interpretation of MDR-TB clinical trials: report of the first Global MDR-TB Clinical Trials Landscape Meeting
por: Mitnick, Carole D, et al.
Publicado: (2015)

Coronaphobia and chronophobia – A psychiatric perspective
por: Naguy, Ahmed, et al.
Publicado: (2020)

Micro- and small-scale enterprises’ financing preference in line with POH and access to credit: empirical evidence from entrepreneurs in Ethiopia
por: Meressa, Hayelom Abrha
Publicado: (2022)

Bedaquiline, pretomanid and linezolid for treatment of extensively drug resistant, intolerant or non-responsive multidrug resistant pulmonary tuberculosis
por: Conradie, Francesca, et al.
Publicado: (2020)

Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis
por: Gopalan, Narendran, et al.
Publicado: (2016)

Xpert Ultra Can Unambiguously Identify Specific Rifampin Resistance-Conferring Mutations
por: Ng, Kamela C. S., et al.
Publicado: (2018)

Acquired rifampicin resistance during first TB treatment: magnitude, relative importance, risk factors and keys to control in low-income settings
por: Van Deun, Armand, et al.
Publicado: (2022)

Treatment delay among tuberculosis patients in Tanzania: Data from the FIDELIS Initiative
por: Hinderaker, Sven Gudmund, et al.
Publicado: (2011)

Enhanced patient research participation: a Photovoice study in Blantyre Malawi
por: Bates, Maya Jane, et al.
Publicado: (2018)

Tackling two pandemics: a plea on World Tuberculosis Day
por: Wingfield, Tom, et al.
Publicado: (2020)

Economic evaluation of a shortened standardised treatment regimen of antituberculosis drugs for patients with multidrug-resistant tuberculosis (STREAM): study protocol
por: Gama, Elvis, et al.
Publicado: (2016)

Brucella melitensis prosthetic joint infection in a traveller returning to the UK from Thailand: Case report and review of the literature
por: Lewis, Joseph M., et al.
Publicado: (2016)

Household concepts of wellbeing and the contribution of palliative care in the context of advanced cancer: A Photovoice study from Blantyre, Malawi
por: Bates, M. Jane, et al.
Publicado: (2018)

Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda
por: Ssengooba, Willy, et al.
Publicado: (2021)

Discordance of the Repeat GeneXpert MTB/RIF Test for Rifampicin Resistance Detection Among Patients Initiating MDR-TB Treatment in Uganda
por: Ssengooba, Willy, et al.
Publicado: (2021)

The Malawi National Tuberculosis Programme: an equity analysis
por: Simwaka, Bertha Nhlema, et al.
Publicado: (2007)

Indicators of sustainable capacity building for health research: analysis of four African case studies
por: Bates, Imelda, et al.
Publicado: (2011)

Modelling the impact of chest X-ray and alternative triage approaches prior to seeking a tuberculosis diagnosis
por: Shazzadur Rahman, Abu A. M., et al.
Publicado: (2019)

Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines
por: Gomez, Gabriela Beatriz, et al.
Publicado: (2021)

Barriers to accessing TB diagnosis for rural-to-urban migrants with chronic cough in Chongqing, China: A mixed methods study
por: Long, Qian, et al.
Publicado: (2008)

Monocyte unresponsiveness and impaired IL1β, TNFα and IL7 production are associated with a poor outcome in Malawian adults with pulmonary tuberculosis
por: Waitt, Catriona John, et al.
Publicado: (2015)

A comparison of smartphone and paper data-collection tools in the Burden of Obstructive Lung Disease (BOLD) study in Gezira state, Sudan
por: Ahmed, Rana, et al.
Publicado: (2018)

The effect of engaging unpaid informal providers on case detection and treatment initiation rates for TB and HIV in rural Malawi (Triage Plus): A cluster randomised health system intervention trial
por: Bello, George, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_613l0k1uco95d7b70ld8g6qiu2